Search
oxyphenbutazone
Indications:
- postoperative ocular inflammation
- superficial eye injuries
- episcleritis
Adverse effects:
- bone marrow suppression*
* withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression
Laboratory:
- oxyphenbutazone in blood
- oxyphenbutazone in serum/plasma
- oxyphenbutazone in urine
Interactions
drug adverse effects of NSAIDs
monitor with non steroidal anti-inflammatory agents (NSIADs)
General
non-steroidal anti-inflammatory agent (NSAID)
ophthalmic agent (eyedrops)
Database Correlations
PUBCHEM cid=4641